Sit Investment Associates Decreased By $8.78 Million Its Aetna (AET) Stake; Last Week Sharps Compliance Corp. (SMED) Coverage

Sharps Compliance Corp. (NASDAQ:SMED) Logo

Among 3 analysts covering Sharps Compliance (NASDAQ:SMED), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Sharps Compliance has $11 highest and $500 lowest target. $6.33’s average target is 63.57% above currents $3.87 stock price. Sharps Compliance had 8 analyst reports since September 23, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Sharps Compliance Corp. (NASDAQ:SMED) rating on Thursday, October 26. Stifel Nicolaus has “Buy” rating and $6 target. On Monday, April 30 the stock rating was downgraded by Stifel Nicolaus to “Hold”. Stifel Nicolaus maintained Sharps Compliance Corp. (NASDAQ:SMED) on Wednesday, July 19 with “Buy” rating. As per Friday, August 11, the company rating was maintained by Stifel Nicolaus. Stifel Nicolaus maintained Sharps Compliance Corp. (NASDAQ:SMED) rating on Wednesday, September 23. Stifel Nicolaus has “Buy” rating and $11 target. The firm earned “Buy” rating on Monday, August 14 by First Analysis. The company was downgraded on Friday, August 12 by First Analysis. See Sharps Compliance Corp. (NASDAQ:SMED) latest ratings:

30/04/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Hold Old Target: $6 Downgrade
26/04/2018 Broker: Barrington Rating: Buy New Target: $5.0000

Sit Investment Associates Inc decreased Aetna Inc (AET) stake by 41.23% reported in 2017Q4 SEC filing. Sit Investment Associates Inc sold 48,800 shares as Aetna Inc (AET)’s stock declined 6.45%. The Sit Investment Associates Inc holds 69,557 shares with $12.55M value, down from 118,357 last quarter. Aetna Inc now has $57.14 billion valuation. The stock increased 2.39% or $4.08 during the last trading session, reaching $174.67. About 3.20M shares traded or 46.42% up from the average. Aetna Inc. (NYSE:AET) has risen 33.34% since May 12, 2017 and is uptrending. It has outperformed by 21.79% the S&P500.

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. The company has market cap of $62.24 million. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web compliance and training program. It has a 483.75 P/E ratio. The firm also provides Route-Based Pickup Service, a waste management service, which offers medical and hazardous waste pick-up services; TakeAway Recycle System, a solution for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; and Universal Waste Shipback Systems, a solution for the collection, transportation, and recycling of light bulbs, batteries, and other mercury containing devices.

More recent Sharps Compliance Corp. (NASDAQ:SMED) news were published by: Globenewswire.com which released: “Sharps Compliance Reports Fiscal 2018 Third Quarter Results” on April 25, 2018. Also Seekingalpha.com published the news titled: “Sharps Compliance’s (SMED) CEO David Tusa on Q3 2018 Results – Earnings Call Transcript” on April 25, 2018. Streetinsider.com‘s news article titled: “Stifel Downgrades Sharps Compliance (SMED) to Hold (pre-market), ‘Need More Consistent Topline Growth and …” with publication date: April 30, 2018 was also an interesting one.

Investors sentiment decreased to 1 in Q4 2017. Its down 0.57, from 1.57 in 2017Q3. It dived, as 4 investors sold Sharps Compliance Corp. shares while 9 reduced holdings. 5 funds opened positions while 8 raised stakes. 3.87 million shares or 4.85% less from 4.06 million shares in 2017Q3 were reported. Dimensional Fund Advsr Ltd Partnership owns 14,013 shares or 0% of their US portfolio. 26,647 are owned by Northern Trust. Heartland Inc invested 0.05% of its portfolio in Sharps Compliance Corp. (NASDAQ:SMED). Renaissance Techs Ltd Liability holds 0% in Sharps Compliance Corp. (NASDAQ:SMED) or 432,300 shares. 57,439 are held by Geode Capital Mgmt Limited Liability. Anderson Hoagland & Com invested in 20,062 shares or 0.05% of the stock. Natl Bank Of Ny Mellon Corporation holds 13,726 shares. Wells Fargo And Communication Mn stated it has 0% in Sharps Compliance Corp. (NASDAQ:SMED). Tower Rech Llc (Trc) holds 0% or 863 shares in its portfolio. Ranger Inv Mngmt Limited Partnership invested in 379,765 shares or 0.11% of the stock. 28,484 are held by Deutsche Comml Bank Ag. Royal Bancshares Of Canada invested in 0% or 8 shares. Virtu Limited Liability Com has invested 0% in Sharps Compliance Corp. (NASDAQ:SMED). Morgan Stanley has invested 0% in Sharps Compliance Corp. (NASDAQ:SMED). Goodman has 997,355 shares.

The stock increased 1.04% or $0.04 during the last trading session, reaching $3.87. About 12,094 shares traded. Sharps Compliance Corp. (NASDAQ:SMED) has declined 7.71% since May 12, 2017 and is downtrending. It has underperformed by 19.26% the S&P500.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.08, from 0.91 in 2017Q3. It fall, as 69 investors sold AET shares while 345 reduced holdings. 147 funds opened positions while 198 raised stakes. 275.71 million shares or 1.91% less from 281.08 million shares in 2017Q3 were reported. Moreover, Ameriprise Fincl has 0.08% invested in Aetna Inc. (NYSE:AET). Robecosam Ag invested in 2,718 shares. Michael & Susan Dell Foundation holds 86,296 shares. 6,674 are owned by Carroll Fincl. Amer Commercial Bank reported 46 shares or 0% of all its holdings. The Illinois-based First Midwest National Bank Trust Division has invested 0.22% in Aetna Inc. (NYSE:AET). Apg Asset Management Nv invested in 0.07% or 257,743 shares. Univest Corp Of Pennsylvania reported 23,443 shares stake. Chicago Equity Prns Ltd Llc accumulated 32,955 shares. California-based Leisure Cap Mngmt has invested 0.18% in Aetna Inc. (NYSE:AET). 222,472 were accumulated by Renaissance Ltd. Banced owns 0.93% invested in Aetna Inc. (NYSE:AET) for 3,122 shares. Moreover, Oakbrook Invs Limited Liability Corporation has 0.14% invested in Aetna Inc. (NYSE:AET). Penobscot Investment Communication owns 12,060 shares or 0.6% of their US portfolio. Gould Asset Mgmt Ltd Liability Ca stated it has 2,500 shares or 0.2% of all its holdings.

More recent Aetna Inc. (NYSE:AET) news were published by: Seekingalpha.com which released: “We Are Playing The CVS Hand” on May 11, 2018. Also Benzinga.com published the news titled: “Regeneron Pharmaceuticals: Sequencing Its Way to +30% Upside” on May 03, 2018. Nasdaq.com‘s news article titled: “Even After Earnings Beat, Cigna Corporation Stock Still Looks Stuck” with publication date: May 11, 2018 was also an interesting one.

Among 24 analysts covering Aetna (NYSE:AET), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Aetna has $212.0 highest and $12 lowest target. $184.13’s average target is 5.42% above currents $174.67 stock price. Aetna had 74 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets on Friday, October 27 with “Market Perform”. The company was upgraded on Wednesday, January 3 by PiperJaffray. The stock has “Neutral” rating by Wedbush on Tuesday, February 2. The firm has “Hold” rating given on Tuesday, September 5 by Jefferies. The firm has “Outperform” rating by RBC Capital Markets given on Friday, June 9. The firm has “Buy” rating given on Monday, December 18 by Wells Fargo. The company was initiated on Wednesday, January 4 by Piper Jaffray. The stock of Aetna Inc. (NYSE:AET) earned “Hold” rating by Jefferies on Friday, January 8. Piper Jaffray maintained Aetna Inc. (NYSE:AET) on Monday, October 23 with “Hold” rating. As per Tuesday, October 31, the company rating was maintained by Cantor Fitzgerald.

Sharps Compliance Corp. (NASDAQ:SMED) Institutional Positions Chart